human oocytes reprogram adult somatic nuclei type diabetic diploid pluripotent stem cells 
transfer somatic cell nuclei oocytes can give rise pluripotent stem cells consistently equivalent embryonic stem cells- holding promise autologous cell replacement therapy although methods induce pluripotent stem cells somatic cells transcription factors widely used basic research numerous differences induced pluripotent stem cells embryonic stem cells reported- potentially affecting clinical use therapeutic potential diploid embryonic stem-cell lines derived adult cells diseased human subjects systematically investigated parameters affecting efficiency blastocyst development stem-cell derivation show improvements oocyte activation protocol including use kinase translation inhibitors cell culture presence histone deacetylase inhibitors promote development blastocyst stage developmental efficiency varied oocyte donors inversely related number days hormonal stimulation required oocyte maturation whereas daily dose gonadotropin total number metaphase ii oocytes retrieved affect developmental outcome use concentrated sendai virus cell fusion induced increase intracellular calcium concentration causing premature oocyte activation used diluted sendai virus calcium-free medium using modified nuclear transfer protocol derived diploid pluripotent stem-cell lines somatic cells newborn first time adult female type diabetes 
